Our Research

Our Research

>> Research Departments
>> Find Clinical Trials
>> Our Publications
>> Our Research Collaborations


Contact Details

  Street address:
Level 11, KGV Building
Missenden Road
CAMPERDOWN NSW 2050
 
Postal address:
Post Office Box M30
Missenden Road NSW 2050

Phone: (02) 9515-6111
Fax: (02) 9515-9610

Online Feedback
Neurology

Neurology

Our Research

Associate Professor Armin (Mohamed) Nikpour MBBS (Hons), FRACP, BSc (Math) is a neurologist specialising in the management of epilepsy. He is the Director of the Comprehensive Epilepsy Service at Royal Prince Alfred Hospital and University of Sydney. He is also a specialist in Positron Emission Tomography.

A/Professor Nikpour is recognised for his expertise in epilepsy management, particularly imaging and surgical planning. His research involves the use of mathematical and engineering techniques to detect seizures and develop new methods for recording brain waves. His other research interests include the detection and treatment of mood disorders and memory problems that often accompany epilepsy. He has also investigated novel radioligands for the imaging of the brain.

As Head of the Epilepsy Unit, A/Professor Nikpour has developed close collaborations with other specialties including physics, engineering, psychology and neuropsychology.
 
Professor Matthew Kiernan leads the ForeFront Frontotemporal Dementia and Motor Neurodegeration Syndrome Program. The team's work is focused on clinical neurology, in particular disease pathophysiology and treatment strategies of neurological disorders.
The team are currently investigating the mechanisms and possible prevention of neurodegeneration in frontotemporal dementia, motor neurone disease, Kennedy's disease, chemotherapy-induced neurotoxicity, stroke, Machado-Joseph disease, spinal muscular atrophy and other inherited neuropathies.
As the Bushell Professor of Neurology, Professor Matthew Kiernan is dually located at the University of Sydney's, Brain and Mind Research Institute and the Royal Prince Alfred Hospital. Professor Kiernan is also the Co -Director of the Brain and Mind Research Institute - Discovery and Translation. Professor Kiernan provides academic leadership in neurology and promotes partnerships between researchers and healthcare practitioners to optimise the translation of research into improved healthcare practice and policy.
Professor Craig Anderson holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and a Senior Principal Research Fellowship of the National Health and Medical Research Council (NHMRC) of Australia. Professor Craig Anderson is currently President of the Asia Pacific Stroke Organisation, a member of several specialist societies, an editor for the Cochrane Stroke Group, and past-President of the Stroke Society of Australasia. He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and leads several large-scale epidemiological and clinical trial projects in stroke. He has a strong commitment to research, training, policy and service development in stroke around the world, but particularly within the Asian region where the burden of disease is enormous.
 
Multiple Sclerosis Research              
Multiple sclerosis is a disabling inflammatory brain disease that afflicts more than 20,000 Australians at the prime off their life. Our group continues to focus research efforts on biomarkers of MS disease activity and progression with a spectrum of blood, imaging and electrophysiological techniques. Clinical research and MS clinical trials are enriched by the participation of patients attending the BMC Multiple Sclerosis Clinic, a partnership of Sydney University, Royal Prince Alfred Hospital and Multiple Sclerosis Australia.
 
 
MS Clinical Research
MH Barnett, JD Pollard, J Spies, M Taha, S Reddel, T Hardy, H Beadnall, J Barton, A O’Connell
 
Our dedicated MS Clinical Trials Unit has continued to provide patients with access to Phase 2-4 trials of cutting edge MS therapies across the spectrum of disease phenotypes. Coordinated by Dr Marinda Taha, the MS Clinical Trials Unit is the largest in NSW and works in close association with the MS Clinic at BMRI.
 
In 2015, we published the results of our pilot study to improve continence management of patients with MS through a novel tablet-based data capture tool in MS (TaDiMuS) developed in-house. We have further translated this work by implementing automated patient data capture (“Patient Reported Outcomes”) into two nationwide clinical trials.
 
Our participation in the iMed/MSBASE clinical database platform continues to produce high quality, clinically relevant data that has led to 5 high impact publications in 2015 that will guide patient management, and in particular therapeutic strategy and treatment sequencing in MS.
 
With A/Professor Michael Buckland and his team, we are investigating whether circulating factors can be used as biomarkers for MS diagnosis and disease activity monitoring. In this study, “exosomes” in blood samples from patients in the MS clinic are examined for specific signatures. The first phase of this study has been completed with successful development of all required methodological techniques and preliminary analysis of >160 samples collected from patients attending the BMC MS Clinic.
 
MSRA Brain Bank
MH Barnett, M Buckland, Tony Harding and MSRA Team
Established in 2008, the MS Research Australia Brain Bank continues to expand and provide expertly characterized tissue samples to MS researchers in both Australia and internationally. This crucial platform addresses a major factor limiting progress in MS research in the country. Tissue is characterized both with neuroimaging (MRI) or donated brains and using microscopy and immunohistochemistry.
 
Funding: MSRA, University of Sydney, Novartis
 
MS Neuroimaging Research
MH Barnett, T Wang, S Klistorner, R Oliver, H Beadnall, J Barton
In collaboration with the Sydney Neuroimaging Analysis Centre (SNAC), based at the Brain and Mind Centre, we have developed novel MRI biomarkers of myelin and axonal integrity in MS. In particular, our group uses advanced imaging techniques such as diffusion MRI to examine the properties of nerve fibre bundles in the brain. In 2015, we published important work in PLOS One which, for the first time, “decoded” the diffusion changes in the visual pathways of the brain. Our work is already being translated into clinical trials with the commencement of the VISMS (“Visual System in MS”) study in 2015 and the integration of our work with SNAC into international Phase 2 clinical trials of pro-remyelinating drugs in MS.
 
Contact Details:

Brain and Mind Centre
Level 4, 94 Mallett St
Camperdown NSW 2050
Phone Number: (02) 9114-4250
Fax Number: (02) 9114-4254

RPA Department of Neurology
Royal Prince Alfred Hospital
Missenden Road
Camperdown NSW 2050
Phone Number: (02) 9515-7565
Fax Number: (02) 9515-9610

Key Achievements

  • Professor Kiernan was elected President of the Australian and New Zealand Association of Neurologists (ANZAN)
  • ALS - FTD spectrum and eating behaviour and metabolism.
    Dr Rebekah Ahmed and the ForeFront team are conducting investigations into the changes in eating behaviour and metabolism in a variety of patients diagnosed with motor neurone disease and frontotemporal dementia. Her research has discovered changes in metabolism and eating behaviour in motor neurone disease similar to that seen in frontotemporal dementia and this has correlated with a longer survival. This could provide insights into potential targets for disease modifying therapies.
  • Nerve and Muscle Ultrasound.
    Dr Neil Simon as part of his PhD program established a nerve and muscle ultrasound protocol for investigating patients with motor neurone syndromes such as motor neurone disease. This work has been continued by Dr Yuichi Noto a ultrasound specialist from Japan and allowed non-invasive assessment of the nerves and muscles to a greater degree than traditional neurophysiology assessment.
  • Project MinE
    Project MinE was founded by a group of patients and neurologists interested in discovering the origins of motor neurone disease. The aim of the project is to map the full DNA profiles of 15,000 people with motor neurone disease and 7,500 healthy control subjects. In order to achieve this aim multiple sites across 16 countries are collecting samples to contribute to Project MinE. The ForeFront Clinic has been chosen as one of the collaborating sites in Australia. So far just over 7,000 DNA profiles have been collected worldwide. This international collaboration has resulted in two recent publications in Nature Genetics, with results from patients recruited from the ForeFront Clinic. https://www.projectmine.com/
  • MND Brain and Spinal Cord Donor Project
    Since the Motor Neurone Disease Brain and Spinal Cord Donor Project was initiated by Prof Matthew Kiernan and Prof Glenda Halliday the team has recruited 27 motor neurone disease (MND) patient donors. The aim of this project is to gain more information about the cellular causes of MND and how genetic variation affects them with the ultimate goal of determining treatable cellular causes and finding a cure for MND.

Awards/Medals

Prof Matthew Kiernan

  • Fellowship of the Australian Academy of Health and Medical Sciences

Prof Craig Anderson

  • Fellow, Australian Academy of Health and Medical Sciences (appointed from 2015)
  • 2015 Stroke Society of Australasia Excellence in Stroke Award
  • Member, Abstract Review Committee, International Stroke Conference (2014-2016)
  • Member, International Stroke Conference Program Committee of the American Heart Association/American Stroke Association (2015-2018)
  • NHMRC Translational Faculty (member 2013-15)
  • Editorial Board, International Journal of Stroke (from 2015)

Dr Rebekah Ahmed

  • James Lance Young Investigator Award (ANZAN)
  • Motor Neurone Disease Research Institute of Australia - PhD Top-up Scholarship (2014 - 2016) 'Eating, autonomic and sexual dysfunction in frontotemporal dementia and motor neurone disease.' Ahmed, R. ($30,000)
  • American Academy of Neurology International Scholarship (2015)
  • Buzzard Dunlop Fund for Alzheimer's Research Fund (2015)
  • ForeFront award for best Clinical paper (2015)
  • Motor Neurone Disease Research Institute of Australia PhD Top up Grant (2014-2016)

Dr Sharpley Hsieh

  • Graham Linford MND Postdoctoral Fellowship (2013-2015)

Jashelle Caga

  • NHMRC Public Health and Health Services Postgraduate Research Scholarship
  • Nina Buscombe Award

Dr Nidhi Garg

  • Inaugural ANZAN Education and Research Foundation/NHMRC Postgraduate award
  • Motor Neurone Disease Research Institute of Australia PhD Award

Dr Thanuja Dharmadasa

  • Motor Neurone Disease Research Institute of Australia PhD Award PhD
  • Top up award from the Yugilbar Foundation (2016-2019)
  • PhD Top up award from Rotary (2016-2019)

 


Research Staff

  • Associate Professor Cindy Lin
  • Dr Rebekah Ahmed (Neurologist, PhD student)
  • Dr Emma Devenney (Neurologist, PhD student)
  • Dr Susanna Park (Senior Lecturer)
  • Dr Tim Howells (Postdoctoral Research Fellow)
  • Dr Sharpley Hsieh (Clinical Neuropsychologist, Postdoctoral Research Fellow)
  • Jashelle Caga (Health Psychologist, PhD Student)
  • Dr Anne Hogden (Occupational Therapist, Postdoctoral Research Fellow)
  • Dr Michael Lee (Neurophysiologist & Physiotherapist, Postdoctoral Research Fellow)
  • Dr William Huynh (Neurologist, Postdoctoral Research Fellow)
  • Dr Nidhi Garg (Neurologist, PhD Student)
  • Dr Thanuja Dharmadasa (Neurologist, PhD Student)
  • Dr Emily Mathey (Postdoctoral Fellow)
  • Margie Zoing (MND CNC)
  • Dr Yuichi Noto (Neurologist, Japanese visiting researcher)
  • Dr Jose Mattamala Capponi (Neurologist, Chilean visiting researcher)
  • Hannah Timmins (Research Assistant)
  • Elizabeth Highton-Williamson (Research Assistant)
  • Tiffany Li (Research Assistant)
  • Nicollette Thornton (Research Assistant)
  • Eleanor Ramsey (Research Coordinator)

Higher Degree Students:
  • Dr Rebekah Ahmed (Neurologist, PhD student)
  • Dr Neil Simon (Neurologist, PhD Student)
  • Dr Emma Devenney (Neurologist, PhD student)
  • Dr Nidhi Garg (PhD Student)
  • Jashelle Caga (Health Psychologist, PhD Student)
  • Dr Thanuja Dharmadasa (Neurologist, PhD Student)
  • Dr Tim Howells (Postdoctoral Research Fellow)
  • Dr Sharpley Hsieh (Clinical Neuropsychologist, Postdoctoral Research Fellow)
  • Dr Anne Hogden (Occupational Therapist, Postdoctoral Research Fellow)
  • Dr Michael Lee (Neurophysiologist & Physiotherapist, Postdoctoral Research Fellow)
  • Dr William Huynh (Neurologist, Postdoctoral Research Fellow)
  • Edward Chan (Supervisor C Anderson) MD/MPhil joint degree enrolment at The University of Sydney.2012-15
  • Anubhav Saxena (Supervisor C Anderson) MD/MPhil joint degree enrolment at The University of Sydney. 2012-15.
  • Sully Fuentes (Supervisor C Anderson) enrolled for PhD at The University of Sydney. 2012-16.
  • Susanne Grewe (Supervisor C Anderson) enrolled for PhD at The University of Sydney. 2012-16.
  • Paula Munoz Venturelli (Supervisor C Anderson) enrolled for PhD at The University of Sydney 2014-18.
  • Xiaoying Chen (Supervisor C Anderson) enrolled for PhD at The University of Sydney 2014-18.
  • Xia Wang (Supervisor C Anderson) enrolled for PhD at The University of Sydney 2014-18.
  • Candice Delcourt (Supervisor C Anderson) enrolled for PhD at The University of Sydney. 2014-18
  • Danni Zheng (Co-Supervisor C Anderson) enrolled for PhD at The University of Sydney. 2014-18
  • Ying Xu (Co-supervisor C Anderson) enrolled for MPhil at The University of Sydney. 2014-15


Publications and Presentations

Publication Details:

Associate Professor Armin (Mohamed) Nikpour:

  1. Thayer Z, Wong C, Mohamed A, Miller L. Improving Memory in Patients with Epilepsy: Considering the Impact of Anti-Epileptic Drugs, Low Mood and/or Surgery on Memory Training Program Outcomes. Int J Neurorehabilitation 2015;2:2376-0281.10001.
  2. Ricci M, Mohamed A, Savage G, Miller LA. Disruption of learning and long-term retention of prose passages in patients with focal epilepsy. Epilepsy & Behavior 2015; 51:104-11.
  3. Ricci M, Mohamed A, Savage G, Boserio J, Miller LA. The impact of epileptiform abnormalities and hippocampal lesions on retention of recent autobiographical experiences: Adding insult to injury? Neuropsychologia 2015;66:259-66.
  4. Miller LA, Flanagan E, Mothakunnel A, Mohamed A, Thayer Z. Old dogs with new tricks: Detecting accelerated long-term forgetting by extending traditional measures. Epilepsy & Behavior 2015;45:205-11.
  5. Knopman AA, Wong CH, Stevenson RJ, et al. The relationship between neuropsychological functioning and FDG-PET hypometabolism in intractable mesial temporal lobe epilepsy. Epilepsy & Behavior 2015;44:136-42.
  6. Hardy TA, Beadnall HN, Sutton IJ, et al. Baló's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis? Journal of the neurological sciences 2015;348:279-81.
  7. Gandy M, Sharpe L, Perry KN, et al. Anxiety in epilepsy: A neglected disorder. Journal of psychosomatic research 2015;78: 149-55.

Professor Matthew Kiernan:

  1. Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, Hodges JR. (2016). The frontotemporal dementia-motor neuron disease continuum. Lancet. doi: 10.1016/S0140-6736(16)00737-6
  2. Noto YI, Shibuya K, Vucic S, Kiernan MC (2016); Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis: Expert Rev Neurother. Jun 17:1-8
  3. Halliday GM, Kiernan MC, Kril JJ, Mito R, Masuda-Suzukake M, Hasegawa M, McCann H, Bartley L, Dobson-Stone C, Kwok JB, Hornberger M, Hodges JR, Tan RH. (2016); TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia: J Neurol Sci. Jul 15; 366:197-201. doi: 10.1016/j.jns.2016.05.005.
  4. Ahmed RM, Caga J, Devenney E, Hsieh S, Bartley L, Highton-Williamson E, Ramsey E, Zoing M, Halliday GM, Piguet O, Hodges JR, Kiernan MC (2016); Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival: J Neurol. 2016 Jun 3; PMID: 27260291
  5. Kiernan MC. (2016); The Babinski sign: Pract Neurol. Jun 8. pii: practneurol-2016-001417. doi: 10.1136/practneurol-2016-001417
  6. Huynh W, Pickering H, Howells J, Murray J, Cormack C, Lin CS, Vucic S, Kiernan MC, Krishnan AV (2016); Effect of fampridine on axonal excitability in multiple sclerosis: Clin Neurophysiol. Jul;127(7):2636-42. doi: 10.1016/j.clinph.2016.04.010.
  7. Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC (2016); Assessment of the upper motor neuron in amyotrophic lateral sclerosis: Clin Neurophysiol.;127(7):2643-60. doi: 10.1016/j.clinph.2016.04.025.
  8. Geevasinga N, Menon P, Ng K, Van Den Bos M, Byth K, Kiernan MC, Vucic S (2016); Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS; Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jun 1:1-9. PMID: 27249331
  9. Borire AA, Visser LH, Padua L, Colebatch JG, Huynh W, Simon NG, Kiernan MC, Krishnan AV (2016); Utility of maximum perfusion sity as an ultrasonographic marker of intraneural blood flow: Muscle Nerve; 2016 May 26. doi: 10.1002/mus.25200.
  10. Ahmed RM, Devenney EM, Irish M, Ittner A, Naismith S, Ittner LM, Rohrer JD, Halliday GM, Eisen A, Hodges JR, Kiernan MC. (2016); Neuronal network disintegration: common pathways linking neurodegenerative diseases; J Neurol Neurosurg Psychiatry; pii: jnnp-2014-308350. doi: 10.1136/jnnp-2014-308350.
  11. Shibuya K, Park SB, Geevasinga N, Huynh W, Simon NG, Menon P, Howells J, Vucic S, Kiernan MC (2016); Threshold tracking transcranial magnetic stimulation: Effects of age and gender on motor cortical function; Clin Neurophysiol. 2016 Jun;127(6):2355-61. doi: 10.1016/j.clinph.2016.03.009.
  12. Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto YI, Kuwabara S, Kiernan MC, Macaskill P, Vucic S (2016); Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data. Clin Neurophysiol. pii: S1388-2457(16)30023-2. doi: 10.1016/j.clinph.2016.04.005
  13. Hsieh S, Irish M, Foxe D, Caga J, Devenney E, Ahmed R, Hodges JR, Piguet O, Kiernan MC (2016); My Memories Are Important to Me: Changes in Autobiographical Memory in Amyotrophic Lateral Sclerosis; Neuropsychology; PMID: 27182707
  14. Menon P, Geevasinga N, Yiannikas C, Kiernan MC, Vucic S. (2016) Cortical contributions to the flail leg syndrome: Pathophysiological insights. Amyotroph Lateral Scler Frontotemporal Degener. 2016 Feb 18:1-8.
  15. Murray L, Butow PN, White K, Kiernan MC, D'Abrew N, Herz H (2016). Advance care planning in motor neuron disease: A qualitative study of caregiver perspectives. Palliat Med. 2016 Feb 4. pii: 0269216315613902
  16. Bae JS, Ferguson M, Tan R, Mioshi E, Simon N, Burrell J, Vucic S, Hodges JR, Kiernan MC, Hornberger M. (2016). Dissociation of Structural and Functional Integrities of the Motor System in Amyotrophic Lateral Sclerosis and Behavioral-Variant Frontotemporal Dementia. Clin Neurol. 2016 Feb 26.
  17. Hornberger M, Kiernan MC. Emergence of an imaging biomarker for amyotrophic lateral sclerosis: is the end point near? J Neurol Neurosurg Psychiatry. 2016 Feb 29. pii: jnnp-2015-312882. doi: 10.1136/jnnp-2015-312882.
  18. Ahmed RM, Irish M, Henning E, Dermody N, Bartley L, Kiernan MC, Piguet O, Farooqi S, Hodges JR. (2016). Assessment of Eating Behavior Disturbance and Associated Neural Networks in Frontotemporal Dementia. JAMA Neurol. 2016 Jan 25. doi: 10.1001/jamaneurol.2015.4478
  19. Caga J, Turner MR, Hsieh S, Ahmed RM, Devenney E, Ramsey E, Zoing MC, Mioshi E, Kiernan MC. (2016). Apathy is associated with poor prognosis in amyotrophic lateral sclerosis. Eur J Neurol. doi: 10.1111/ene.12959
  20. Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, Hodges JR, Kiernan MC. (2016). Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. doi: 10.1016/S1474-4422(15)00380-4.
  21. Park SB, Vucic S, Cheah BC, Lin CS, Kirby A, Mann KP, Zoing MC, Winhammar J, Kiernan MC. (2016). Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial. EBioMedicine. 2015 Dec 1;2(12):1916-22. doi: 10.1016/j.ebiom.2015.11.022.
  22. Kiernan MC (2016). 35,000 Days on Earth. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2015-312686.
  23. Arnold R, Pussell BA, Kiernan MC, Krishnan AV. (2015). A comparative study to evaluate the effects of peritoneal and hemodialysis on peripheral nerve function. Muscle Nerve. doi: 10.1002/mus.25016
  24. Kwai NC, Arnold R, Poynten AM, Howells J, Kiernan MC, Lin CS, Krishnan AV (2015). In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes. Clin Neurophysiol; doi: 10.1016/j.clinph.2015.11.047.
  25. Kiernan MC, Turner MR (2015). Lou Gehrig and the ALS split hand. Neurology. doi: 10.1212/WNL.0000000000002172
  26. Tan RH, Kril JJ, McGinley C, Hassani M, Masuda-Suzukake M, Hasegawa M, Mito R, Kiernan MC, Halliday GM (2015). Cerebellar neuronal loss in als cases with ATXN2 intermediate repeat expansions. Ann Neurol. doi: 10.1002/ana.24565.
  27. Devine MS, Ballard E, O'Rourke P, Kiernan MC, Mccombe PA, Henderson RD (2015). Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. doi:10.3109/21678421.2015.1125502
  28. Simon NG, Lagopoulos J, Gallagher T, Kliot M, Kiernan MC (2015). Peripheral nerve diffusion tensor imaging is reliable and reproducible. J Magn Reson Imaging. doi: 10.1002/jmri.25056
  29. Arnold R, Huynh W, Kiernan MC, Krishnan AV (2015). Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis. Curr Med Chem. 22: 1-13 doi: 10.2174/0929867322666151029104452
  30. Devenney E, Bartley L, Hoon C, O'Callaghan C, Kumfor F, Hornberger M, Kwok JB, Halliday GM, Kiernan MC, Piguet O, Hodges JR (2015). Progression in Behavioral Variant Frontotemporal Dementia: A Longitudinal Study. JAMA Neurol. 26:1-9. doi: 10.1001/jamaneurol.2015.2061
  31. Grieve SM, Menon P, Korgaonkar MS, Gomes L, Foster S, Kiernan MC, Vucic S (2015). Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 12:1-8 doi: 10.3109/21678421.2015.1074707
  32. Hsieh S, Leyton CE, Caga J, Flanagan E, Kaizik C, O'Connor CM, Kiernan MC, Hodges JR, Piguet O, Mioshi E (2015). The Evolution of Caregiver Burden in Frontotemporal Dementia with and without Amyotrophic Lateral Sclerosis. J Alzheimer's Dis: 1-11. doi: 10.3233/JAD-150475
  33. Simon NG, Huynh W, Vucic S, Talbot K, Kiernan MC (2015). Motor neuron disease: current management and future prospects. Intern Med J. 45(10):1005-13.
  34. Garg N, Yuki N, Park SB, Barnett MH, Kiernan MC (2015). Acute bulbar, neck and limb weakness with monospecific anti-GT1a antibody: A rare localized subtype of Guillain-Barré sydnrome. Muscle Nerve. DOI: 10.1002/mus.24935
  35. Geevasinga N, Menon P, Nicholson GA, Ng K, Howells J, Kril JJ, Yiannikas C, Kiernan MC, Vucic S (2015). Cortical Function in Asymptomatic Carriers and Patients with C9orf72 Amyotrophic Lateral Sclerosis. JAMA Neurol; 72(11):1268-74. DOI: 10.1001/jamaneurol.2015.1872.
  36. Huynh W, Kiernan MC (2015). Peripheral nerve axonal excitability studies: expanding the neurophysiologist's armamentarium. Cerebellum Ataxias; 3:2-4. DOI: 10.1186/s40673-015-0022-2.
  37. Simon NG, Kiernan MC (2015). Precise correlation between structural and electrophysiological disturbances in MADSAM neuropathy. Neuromuscul Disord 11:904-7. DOI: 10.1016/j.nmd.2015.07.012.
  38. Ahmed RM, Latheef S, Bartley L, Irish M, Halliday GM, Kiernan MC, Hodges JR, Piguet O (2015). Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology. Neurology; 85(15):1310-7. DOI: 10.1212/WNL.0000000000002018
  39. Menon P, Geevasinga N, Yiannikas C, Howells J, Kiernan MC, Vucic S (2015). Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol. 14(5):478-84. doi: 10.1016/S1474-4422(15)00014-9.
  40. Ittner LM, Halliday GM, Kril JJ, Götz J, Hodges JR, Kiernan MC. (2015). FTD and ALS--translating mouse studies into clinical trials. Nat Rev Neurol. 11: 360-366. doi:10.1038/nrneurol.2015.65
  41. Menezes MP, Farrar MA, Webster R, Antony J, O'Brien K, Ouvrier R, Kiernan MC, Burns J, Vucic S. (2015). Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter. Clin Neurophysiol. doi: 10.1016/j.clinph.2015.05.012.
  42. Ahmed RM, Newcombe RE, Piper AJ, Lewis SJ, Yee BJ, Kiernan MC, Grunstein RR (2015). Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev. 26:33-42. doi: 10.1016/j.smrv.2015.05.007.
  43. Huynh W, Vucic S, Krishnan AV, Lin CS, Kiernan MC (2015). Exploring the Evolution of Cortical Excitability Following Acute Stroke. Neurorehabil Neural Repair. doi: 10.1177/1545968315593804
  44. Tan RH, Kril JJ, Fatima M, McGeachie A, McCann H, Shepherd C, Forrest SL, Affleck A, Kwok JB, Hodges JR, Kiernan MC, Halliday GM (2015). TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain. 138(10):3110-22. doi: 10.1093/brain/awv220
  45. Caga J, Ramsey E, Hogden A, Mioshi E, Kiernan MC (2015). A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Support Care. 13(4):1019-24. doi: 10.1017/S1478951514000881
  46. Huynh W, Kiernan MC (2015). A unique account of ALS in China: exploring ethnic heterogeneity. J Neurol Neurosurg Psychiatry doi:10.1136/jnnp-2015-311293
  47. De Silva D, Hsieh S, Caga J, Leslie FV, Kiernan MC, Hodges JR, Mioshi E, Burrell JR. (2015). Motor function and behaviour across the ALS-FTD spectrum. Acta Neurol Scand. doi: 10.1111/ane.12471
  48. Hsieh S, Caga J, Leslie FV, Shibata M, Daveson N, Foxe D, Ramsey E, Lillo P, Ahmed RM, Devenney E, Burrell JR, Hodges JR, Kiernan MC, Mioshi E. (2015). Cognitive and Behavioral Symptoms in ALSFTD: Detection, Differentiation, and Progression. J Geriatr Psychiatry Neurol. doi: 10.1177/0891988715598232
  49. Simon NG, Lee M, Bae JS, Mioshi E, Lin CS, Pfluger CM, Henderson RD, Vucic S, Swash M, Burke D, Kiernan MC. (2015). Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis. J Neurol. 2015 Apr 7. In press
  50. Ahmed RM, Kaizik C, Irish M, Mioshi E, Dermody N, Kiernan MC, Piguet O, Hodges JR. (2015). Characterizing Sexual Behavior in Frontotemporal Dementia. J Alzheimers Dis; 46(3):677-86. doi: 10.3233/JAD-150034
  51. Lee M, Kiernan MC, Macefield VG, Lee BB, Lin CS. (2015). Short-term peripheral nerve stimulation ameliorates axonal dysfunction after spinal cord injury. J Neurophysiol 113(9):3209-18. doi: 10.1152/jn.00839.2014.
  52. Kiernan MC, (2015). Palliative care in amyotrophic lateral sclerosis. Lancet Neurol 14(4):347-8. doi: 10.1016/S1474-4422(14)70289-3.
  53. Kiernan MC, (2015). Does dysfunction of the mirror neuron system contribute to symptoms in amyotrophic lateral sclerosis? Clin Neurophysiol. 126(7):1288-94. doi: 10.1016/j.clinph.2015.02.003.
  54. Geevasinga N1, Menon P, Sue CM, Kumar KR, Ng K, Yiannikas C, Kiernan MC, Vucic S (2015). Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia. Eur J Neurol. 22(5):826-31, e57-8. doi: 10.1111/ene.12669.
  55. Eisen A, Lemon R, Kiernan MC, Hornberger M, Turner MR (2015). Does dysfunction of the mirror neuron system contribute to symptoms in amyotrophic lateral sclerosis? Clin Neurophysiol. 126(7):1288-94. doi: 10.1016/j.clinph.2015.02.003.
  56. Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS (2015). Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. 0:1-13. doi:10.1136/jnnp-2014-309697
  57. Kiernan MC, (2015). A fine neuroscience vintage. Journal of Neurology Neurosurgery and Psychiatry 86(1):1-2. doi:10.1136/jnnp-2014-309899
  58. Carswell C, Northey LC, Davies L, Yuki N, Kiernan MC (2015). Progressive bilateral facial weakness. Practical Neurology 15(1): 76-9. doi:10.1136/practneurol-2014-000989
  59. Geevasinga N, Menon P, Howells J, Nicholson GA, Kiernan MC, Vucic S. (2015). Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis. JAMA Neurology 72(1): 49-57. doi: 10.1001/jamaneurol.2014.2940.

Professor Craig Anderson

  1. Radholm K, Arima H, Lindley RI, Wang J, Tzourio C, Robinson, Heeley, Anderson CS, Chalmers J, for the INTERACT2 Investigators. Older Age is a Strong Predictor for Poor Outcome in Intracerebral Haemorrhage: the INTERACT2 study. Age and Ageing 2015 44(3) 422-427 online 13 December doi: 10.1093/ageing/afu198.
  2. Arima H, Heeley E, Delcourt C, Hirakawa, Wang X, Woodward M, Robinson T, Stapf C, Parsons M, Lavados PM, Huang Y, Wang J, Chalmers, Anderson CS and for the INTERACT2 Investigators. Optimal Achieved Blood Pressure in Acute Intracerebral Haemorrhage. Neurology 2015 online 31 December 2014 doi:10. 1212/WNL. 0000000000001205.
  3. Wang X, Arima H, Al-Shahi Salman R, Woodward M, Heeley E, Stapf C, Lavados PM, Robinson T, Huang Y, Wang J, Delcourt C, Anderson CS, for the INTERACT Investigators. Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Haemorrhage: pooled analysis of the INTERACT Studies. Cerebrovascular Diseases 2015 39: (3-4) 242-248 doi: 10.1159/000381107.
  4. Bohm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener H, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O’Donnell M, Yusuf S. Systolic Blood Pressure Variation and Mean heart Rate is Associated with Cognitive Dysfunction in Patients with High Cardiovascular Risk. HypertensionAHA 2015 8 (1) doi: 10.1161/HYPERTENSIONAHA.114.04568.
  5. Sato S, Heeley E, Arima H, Delcourt C, Hirakawa Y, Pamidimukkala V, Li Z, Tao Q, Xu Y, Hennerici MG, Robinson T, Tzourio C, Lindley RI, Chalmers J, Anderson CS for the INTERACT Investigators. Higher Mortality in Patients with Right Hemispheric Intracerebral Haemorrhage: INTERACT 1 and 2.  Journal of Neurology, Neurosurgery & Psychiatry 2015 doi: 10.1136/jnnp-2014-309870.
  6. Chan E, Anderson CS, Wang X, Arima H, Saxena A, Moullaali TJ, Heeley E, Delcourt C, Wu G, Wang J, Chen G, Lavados PM, Stapf C, Robinson T, Chalmers J, Huang Y for the INTERACT2 Investigators. Significance of Intraventricular Haemorrhage in Acute Intracerebral Haemorrhage, Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Results.  Stroke  2015 46: 653-658 doi: 10.1161/STROKEAHA.114.008470.
  7. Priglinger M, Arima H, Anderson C, Krause M. No Relationship of Lipid-Lowering Agents to Haematoma Growth Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trials Studies.  Stroke 2015 46 (3) 857-859 doi: 10.1161/STROKEAHA.114.007664
  8. Adey-Wakeling Z, Arima H, Crotty M, Leyden J, Kleinig T, Anderson CS, Newbury J for the SEARCH study collaborative. Incidence and associations of hemiplegic shoulder pain post stroke: A prospective population based study. Archives of Physical Medicine and Rehabilitation 2015 Feb;96(2):241-247.e1. doi: 10.1016/j.apmr.2014.09.007.
  9. Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, Lavados P, Olavarria V, Arima H, Fuentes S, Nguyen HT, Lee TH, Parsons MW, Levi C, Demchuk AM, Bath PMW, Broderick JP, Donnan GA, Martins S, Pontes-Nete OM, Silva F, Pandian J, Ricci S, Stapf C, Woodward M, Wang J, Chalmers, Anderson CS and for the ENCHANTED Investigators. Rationale, Design, and Progress of the ENCHANTED Trial: an International Multicentre 2x2 Quasi-Factorial Randomised Controlled Trial of Low v Standard-dose rt-PA and Early Intensive v Guideline Recommended Blood Pressure Lowering in Patients with Acute Ischaemic Stroke Elegible for Thrombolysis Treatment. International Journal of Stroke 2015 online 2 April Doi: 10.1111/ijs.12486
  10. Yang J, Arima H, Wu G, Heeley E, Delcourt C, Zhou J, Chen G, Wang X, Zhang S, Yu S, Chalmers J, Anderson CS. Prognostic Significanc of Perihaematomal Oedema in Acute Intracerebral Haemorrhage Pooled Analysis of the INTERACT Trial Studies. Stroke 2015 46(4) 1009-1013 doi:10.116/STROKEAHA. 114.007154.
  11. Pandian JD, Felix C, Kaur P, Sharma D, Julia L, Toor G, Arora R, andhi DBC, Verma SJ, Anderson CS, Langhorne P, Murthy GVS, Hackett ML, Maulik PK, Alim M, Harvey LA, Jan S, Walker M, Forster A, Lindley R. Family-led Rehabilitation After Stroke in India: the ATTEND Pilot Study. International Journal of Stroke online 9 March 2015 doi: 10.111/ijs. 12475.
  12. Palesch YY, Yeatts SD, tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauc EC, Jovin TG, Yan B, von Kummer R, Molina CA Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Lpilker J, Carrozzella J, Ryckborst KJ, Scott Janis L, Simpson A, Simpson KN, Broderick JP for the Interventional Management of Stroke III Investigators. Twelve Month Clinical and Quality of Life Outcomes in the Interventional Management of Stroke III Trial. Stroke 2015 46(5) 1321 online 9 April doi: 10.1161/STROKEAHA/115.009180.
  13. Wang X, Arima H, Heeley E, Delcourt C, Huang Y, Wang J, Stapf C, Robinson T, Woodward M, Chalmers J, Anderson CS. Magnitute of Blood Pressure Reduction and Clinical Outcomes in acute Intracerebral Haemorrhage Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Study. Hypertension 2014 65(5) 1026.
  14. Muñoz-Venturelli P, Olavarría V, González F, Bruser A, Lavados P, Arima H, Anderson CS. Head Position in the Early Phase of Acute Ischemic Stroke: An International Survey of Current Practice. 21 April 2015 pii: S1052-3057(15)00135-4. doi: 10.1016/ j.jstrokecerebrovasdis. 2015.03.023.
  15. Enkhtungalag B, Batjargal J, Chimedsuren O, Tsogzolmaa B, Anderson CS, Webster J. Developing a National Salt Reduction Strategy in Mongolia. Cardiovascular Diagnosis and Therapy 2015 June; 5(3):229-37. doi: 10.3978/j.issn.2223-3652.2015.04.11
  16. Cukierman-Yaffe T, Anderson C, Teo K, Gao P, Gerstein H C, Yusuf S. Dysglycemia & cognitive dysfunction & ill-health in people with high CV risk: results from the ONTARGET/TRANSCEND studies Unsuccessful Aging & Dysglycemia. Journal of Clinical Endocrinology and Metabolism 2015 July 100(7):2682-9.
  17. Parry-Jones AR, Wang X, Sato S, Mould WA, Vail A, Anderson CS, Hanley DF. Edema Extension Distance: Outcome Measure for Phase II Clinical Trials Targeting Edema After Intracerebral Hemorrhage. Stroke 2015 June 46(6):e137-40.doi:10.1161/ STROKEAHA. 115.008818.
  18. Muñoz-Venturelli P, Arima H, Lavados P, Brunser A, Peng B, Cui L, Song L, Billot L, Boaden E, Hackett ML, Heritier S, Jan S, Middleton S, Olavarría V, Lim JY, Lindley RI, Heeley E, Robinson T, Pontes-Neto O, Natsagdorj L, Lin RT, Watkins C, Anderson CS. Head Position in Stroke Trial (HeadPoST) – Sitting up vs lying flat, positioning of patients with acute stroke: study protocol for a cluster randomised controlled trial. Trials 2015 Jun 5;16:256. doi: 10.1186/s13063-015-0767-1
  19. O’Donnell M, Anderson C, Teo K, Gao P, Sleight P, Dagenais G, Probstfield JL, Mente A, Yusuf S. Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries. Neurology 2015 Jun 2;84(22):2258-65. doi: 10.1212/WNL.0000000000001638.
  20. Heeley E, Anderson CS, Woodward M, Arima H, Robinson T, Stapf C, Parsons M, Lavados PM, Huang Y, Wang Y, Crozier S, Parry-Jones A, Wang J, Chalmers J for the INTERACT2 Investigators. Poor utility of grading scales in acute intracerebral haemorrhage: results from the INTERACT2 trial. International Journal of Stroke 2015 Jun 4. doi: 10.1111/ijs.12518.
  21. Kilkenny MF, Dewey HM, Sundararajan V, Andrew NE, Lannin N, Anderson CS, Donnan GA, Cahilhac DA. Readmissions after stroke: linked data from te Australian Stroke Clinical Registry and hospital databases. Medical Journal of Australia 2015 Jul 20;203(2):102-6.
  22. Carcel C, Anderson CS. Timing of blood pressure lowering in acute ischemic stroke. Current Atherosclerosis Reports 2015 Aug;17(8):520. doi: 10.1007/s11883-015-0520-y
  23. Feigin VL, Krishnamurthi RV, Barker-Collo S, McPherson KM, Barber PA, Paraq V, Arroll B, Bennett DA, Tobias M, Jones A, Witt E, Brown P, Abbott M, Bhattacharjee R, Rush E, Suh FM, Theadom A, Rathnasabapathy Y, Te Ao B, Parmar PG, Anderson C, Bonita R, ARCOS IV Group. 30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies. PLoS One 2015 Aug 20;10(8): e0134609. doi: 10.1371/journal.pone.0134609. eCollection 2015
  24. Mackey J, Brown RD, Sauerbeck L, Hornung R, Moomaw CJ, Koller DL, Foroud T, Deka R, Woo D, Kleindorfer D, Flaherty, Meissner I, Anderson C, Rouleau G, Connolly ES, Huston J Broderick JP. Affected twins in the familial intracranial aneurysm study. Cerebrovascular Disease 2015;39(2):82-6. doi: 10.1159/000369961.
  25. Sato S, Carcel C, Anderson CS. Blood Pressure Management After Intracerebral Hemorrhage. Current Treatment Options Neurology 2015 Dec;17(12):49. doi: 10.1007/ s11940-015-0382-1

Associate Professor Michael Barnett and Multiple Sclerosis Research

  1. Klistorner A, Vootakuru N, … and Barnett, MH. Decoding Diffusivity in Multiple Sclerosis: Analysis of Optic Radiation Lesional and Non-Lesional White Matter. PLoS ONE 2015 10(3): e0122114. doi:10.1371/journal.pone.0122114 .
  2. Ribbons et al. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS. PLoS One. 2015 Jun 5;10(6):e0122686. doi: 10.1371/journal.pone.0122686. eCollection 2015.
  3. Jokubaitis et al. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. Accepted 2/6/2015. MSJ
  4. Ramanathan et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Accepted 3/6/2015. MSJ
  5. Kalincik T, Cutter G, Spelman T, et al. Defining reliable disability outcomes in multiple sclerosis. Brain. in press, accepted 11 July 2015.
  6. Wang C, Beadnall HN, Hatton SN, Bader G, Tomic D, Silva DG, Barnett MH. Automated brain volumetrics measurement in multiple sclerosis: a step closer to clinical application? J Neurol Neurosurg Psychiatry. 2016 Apr 12.
  7. Klistorner A, Wang C, Yiannikas C, Graham SL, Parratt J, Barnett MH. Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study. PLoS One. 2016 Feb 22;11(2):e0149245.
  8. Spelman T, Mekhael L, Burke T, Butzkueven H, Hodgkinson S, Havrdova E, Horakova D, Duquette P, Izquierdo G, Grand'Maison F, Grammond P, Barnett M, Lechner-Scott J, Alroughani R, Trojano M, Lugaresi A, Granella F, Pucci E, Vucic S. Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.  MSBase Study Group. Eur J Neurol. 2016 Jan 19. doi: 10.1111/ene.12929. [Epub ahead of print]
  9.  Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies JM, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E. A new era in the treatment of multiple sclerosis.  Med J Aust. 2015 Aug 3;203(3):139-41, 141e.1. Review.
  10. Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J, Scott R, Lea R, Taylor BV, Stankovich J, Butzkueven H, Gresle M, Laws SM, Petrou S, Hoffjan S, Akkad DA, Graham CA, Hawkins S, Glaser A, Bedri SK, Hillert J, Matute C, Antiguedad A; A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.  ANZgene Consortium, Wiley JS. Hum Mol Genet. 2015 Oct 1;24(19):5644-54. doi: 10.1093/hmg/ddv278. Epub 2015 Jul 17.
  11. He A, Spelman T, Jokubaitis V, Havrdova E, Horakova D, Trojano M, Lugaresi A, Izquierdo G, Grammond P, Duquette P, Girard M, Pucci E, Iuliano G, Alroughani R, Oreja-Guevara C, Fernandez-Bolaños R, Grand'Maison F, Sola P, Spitaleri D, Granella F, Terzi M, Lechner-Scott J, Van Pesch V, Hupperts R, Sánchez-Menoyo JL, Hodgkinson S, Rozsa C, Verheul F, Butzkueven H, Kalincik T. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.  MSBase Study Group. JAMA Neurol. 2015 Apr;72(4):405-13. doi: 10.1001/jamaneurol.2014.4147. Erratum in: JAMA Neurol. 2015 Aug;72(8):950.

Presentations:

Prof Matthew Kiernan

Organisational and Chairing Roles For Scientific Meetings

  1. 26th International Symposium ALS/MND, Orlando, USA; 1 - 13 December (2015). • Co-Chair
  2. MND Australia Research Meeting, November (2015), Brain & Mind Centre, Sydney Nursing School, University of Sydney • Chair, Co-organizer
  3. Marie Bashir Institute, MBI CNS Infection, Inflammation and Immunology (CNS I3) node symposium, November (2015), Sydney • Chair, Brain and Mind Centre Platforms
  4. ForeFront Asia Pacific FTD/MND Meeting, University of Sydney, Sydney, October (2015), Sydney
  5. 15th Asian Oceanian Congress of Neurology • Co-Chair, Scientific and Programme Committee, Malaysia (2015)

Invited Presentations at National and International Meetings

  1. Freeze MND (June 2016) Melbourne, invited attendee
  2. ANZAN Meeting (May 2016) Perth, Australia (Speaker)
  3. Irish Neurological Association Meeting, (May 2016), Limerick, Ireland. (Speaker)
  4. ALS Clinical Trials Guidelines (March 16th- 19th, 2016), Airlie House, Warrenton, VA Hotel & Conference Center, USA.
  5. Sydney Health Partners Annual Forum (February 2016), Sydney, Australia. (Speaker)
  6. Invitation to the launch of the Deloitte Access Economics report 'Economic Analysis of motor neurone disease in Australia', (February 2016), Parliament House, Canberra, Australia. (Speaker)
  7. Australian Association of Clinical Geneticists, February 2016, Sydney, Australia (Speaker)
  8. Workshop with the NSW Office of Health & Medical Research to discuss collaboration on dementia studies (February 2016) Sydney, Australia
  9. NNIDR Team Grant Meeting, (February 2016) Canberra, Australia
  10. Invitation to RMIT, Melbourne, Australia, January 2016; Meeting to discuss links between Dementia and MND.
  11. British Medical Journal (BMJ) Editors Retreat Journal of Neurology; Neurosurgery and Psychiatry; London, UK, December 2015
  12. XXII World Congress of Neurology (WCN 2015), Santiago, Chile; October 31-November 5
  13. 1st Brain Mapping Day; Society for Brain Mapping & Therapeutics, Parliament House, Canberra Australia 12th October 2015 (Plenary Speaker)
  14. 1st Annual Scientific Meeting, Annual General Meeting and Induction of new Fellows at the John Curtin School of Medical Research, ANU Canberra, October 2015
  15. 16th Clinical Neurophysiology Workshop of the Australian and New Zealand Association of Neurologists; Sheraton Mirage Resort, Southport, Queensland 27-30 September, 2015
  16. 1st International Taiwanese Congress of Neurology and Annual Meeting of Taiwan Neurological Society; Taiwan; May 2015; 'Neuropathy in a Modern Era' & 'Amyotrophic Lateral Sclerosis: Clinical Translations and New Insights'. (Keynote Speaker)
  17. 9th Alzheimer's & Parkinson's disease; Symposium; Brisbane, Australia; 23th & 24th April 2015;' Motor degeneration and dementia: a clinical dissection'; (Keynote Lecture)
  18. British Medical Journal (BMJ) Editors Retreat Journal of Neurology, Neurosurgery and Psychiatry, London, UK March 2015
  19. 12th Brain 2015: Asia Pacific Multidisciplinary Meeting for Nervous System Diseases: 'Treatment Strategies for ALS' 6 February 2015; Hong Kong, China (Plenary Speaker)

Prof Craig Anderson

  1. Plenary speaker “Hyper Acute Nursing Care Policies/Strategies: What is the evidence?”. AHA International Stroke Conference 2015, State of the Science Stroke Nursing Symposium. Nashville. February 2015.
  2. Invited speaker “What Critical Volume of Intraventricular Haemorrhage is Important in ICH? Interact2 results”. AHA International Stroke Conference 2015. Nashville. February 2015.
  3. Invited speaker “Outcomes for Younger Adults with Stroke in the Australian Stroke Clinical Registry (AuSCR)”. European Stroke Organisation. Glasgow. April 2015.
  4. Invited speaker “Updates on Hypertension related ICH”. European Stroke Organisation. Glasgow. April 2015.
  5. Convenor “Lessons from Asian Practice to Europe”. European Stroke Organisation. Glasgow. April 2015.
  6. Invited speaker “Stroke: the Difference Between the East and the West”.  First International Taiwanese Congress of Neurology. Taiwan. May 2015.
  7. Invited speaker “Differences between the East and West in Risk Factors for Acute Stroke”. Tianfu International Stroke Conference. Chengdu, China. May 2015.
  8. Invited speaker “How to Design and Conduct a Clinical Study: Experience from the Quest Study”. Tianfu International Stroke Conference. Chengdu, China. May 2015.
  9. Invited speaker “How to Interpret Study Results and how to Write the Discussion Section of a Paper”. Tianfu International Stroke Conference. Chengdu, China. May 2015.
  10. Invited speaker “Differentiating Stroke from Other Neurological Syndromes”. 1st Annual Conference of Chinese Stroke Association and 2015 Tiantan International Stroke Conference. Beijing, China. June 2015.
  11. Invited speaker “Overview of AHA/ASA, Management of ICH Guidelines”. 1st Annual Conference of Chinese Stroke Association and 2015 Tiantan International Stroke Conference. Beijing, China. June 2015.
  12. Invited speaker “Blood Pressure Management in Acute Ischaemic and Haemorrhagic Stroke”. ASEAN. Singapore. July 2015.
  13. Invited speaker “How to Write a Scientific Paper”. ASEAN. Singapore. July 2015.
  14. Invited speaker “Survival Advantage from Stroke Unit Care: Evidence from the Australian Stroke Clinical Registry”. SSA 2015. Melbourne, Australia. September 2015.
  15. Invited speaker “Clinical Outcomes Among Younger Adults with Stroke Registered in the Australian Stroke Clinical Registry”. SSA 2015. Melbourne, Australia. September 2015.
  16. Session chair “Implications for Strong Evidence for Mechanical Thrombectomy for the Asia-Pacific Region”. APSC 2015. Kuala Lumpur. October 2015.
  17. Invited speaker “Blood Pressure Control in Intracerebral Haemorrhage: What Should be Done? APSC 2015. Kuala Lumpur. October 2015.
  18. Speaker “Head Position In Stroke Trial Headpost Challenges To Conducting A Large Scale Nursing Care Trial”. ACTA 2015 International Clinical Trials Symposium. Sydney, Australia. October 2015.
  19. Invited speaker “Management Of Acute Intracerebral Haemorrhage – When To Start And How To Treat”. XXII World Congress of Neurology. Santiago, Chile. November 2015.

Research Grants

GRANTING BODY AWARDEES PROJECT TITLE Total $$ Years
    Project MINE MNDRIA   $   200,000 2015
National Health & Medical Research Council (NH&MRC) Prof Matthew Kiernan “Frontotemporal dementia and motor neurodegenerative syndromes”; Program Grant # 1037746  $11,362,045 2013-2018
Bushell Chair of Neurology Prof Matthew Kiernan Bushell Chair Fund   2013-
Motor Neurone Disease Research Institute of Australia Dr James Howells Bill Gole Fellowship  $   300,000 2015-2017
Dementia Team Grant Prof Glenda Halliday et al Non-Alzheimer’s disease degenerative dementias: identifying prodromal genetic/familial phenotypes, modifying factors, and protein variants involved in progression  $ 6,449,246 2015-2019
National Health and Medical Research Council (NHMRC)/Project Grants Kiernan M, Lin C, Pollard J, Mathey E, Park S, Vucic S Nodal Function in Peripheral Neuroinflammatory Disorders: Target Antigens, Functional Significance and Treatment Response  $   605,172 2016-2019
NHMRC/Project Grant Park S, Krishnan A, Goldstein D, Friedlander M, Lin C, Kwok J, Boyle F, Horvath L, Haas M, Barnes E Long Term Nerve Damage in Cancer Survivors: identification of risk factors & Optimal Assessment Strategies  $   818,440 2015-2019
HMR+ Implementation Fund Naismith S, Valenzuela M, Hickie I, Anderson C, Neal B, Simpson S, Lagopoulos J, Marshall N, Glozier N, Calvo R, Kurrie S, Flood V. The Healthy Brain Ageing e-health platform: A novel approach for large scale intervention trials addressing vascular and other modifiable risk factors.  $   161,864 2015
NHMRC APP1081356 Anderson CS Research Fellowship – Senior Principal Research Fellowship (SPRF) - Funding 5 years  $   836,915 2015-

Contact details for department

Head of Department: A/Professor Armin (Mohamed) Nikpour

Department/Unit: Neurology
Address:
RPA Hospital
Missenden Road
Camperdown NSW 2050
Telephone: (02) 9515 7565
Facsimile: (02) 9515 9610
Web: http://www.slhd.nsw.gov.au/research/
Email: armin@sydneyneurology.com.au